Literature DB >> 2253906

Paf-acether synthesis by Helicobacter pylori.

Y Denizot1, I Sobhani, J C Rambaud, M Lewin, Y Thomas, J Benveniste.   

Abstract

Clinical studies suggest that Helicobacter pylori may play a role in the pathogenesis of gastroduodenal ulcers in man but direct evidence of mucosal injury by this microorganism is still lacking. Paf-acether (paf) causes a number of disorders including ischaemic bowel necrosis and gastroduodenal ulceration. Since paf is produced by Escherichia coli, we investigated whether it could be synthesised by H pylori. Five H pylori isolates were collected from antral biopsy specimens from patients with gastritis and duodenal ulcer and cultured with selective antibiotics. Colonies obtained from both blood agar and brucella broth medium were used. Paf was determined by platelet aggregation assay after ethanolic extraction and subsequent purification by high performance liquid chromatography. Paf was detected in H pylori in blood agar plates (680 (390) pg paf/1 x 10(6) organisms) but not in bacteria cultured on brucella broth medium. Supplementation of the latter medium with lyso paf and acetyl-CoA, two paf precursors present in high amounts in the mammalian intestine, induced paf production in three of five isolates. The platelet aggregating material extracted from H pylori exhibited biological and physiochemical characteristics identical to those of paf released from eukaryotic cells. These findings suggest that H pylori may add to the local production of paf in inflamed gastric mucosa.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2253906      PMCID: PMC1378692          DOI: 10.1136/gut.31.11.1242

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  21 in total

1.  Structural analysis of purified platelet-activating factor by lipases.

Authors:  J Benveniste; J P Le Couedic; J Polonsky; M Tence
Journal:  Nature       Date:  1977-09-08       Impact factor: 49.962

2.  Campylobacter-like organisms in the stomach of patients and healthy individuals.

Authors: 
Journal:  Lancet       Date:  1984-06-16       Impact factor: 79.321

3.  Antihypertensive activity of an alkyl ether analog of phosphatidylcholine.

Authors:  M L Blank; F Snyder; L W Byers; B Brooks; E E Muirhead
Journal:  Biochem Biophys Res Commun       Date:  1979-10-29       Impact factor: 3.575

4.  Is platelet activating factor (PAF) a mediator of endotoxin shock?

Authors:  Z Terashita; Y Imura; K Nishikawa; S Sumida
Journal:  Eur J Pharmacol       Date:  1985-02-26       Impact factor: 4.432

5.  Biosynthesis of platelet-activating factor (PAF)acether). III. Formation of PAF-acether from synthetic substrates by stimulated murine macrophages.

Authors:  J M Mencia-Huerta; R Roubin; J L Morgat; J Benveniste
Journal:  J Immunol       Date:  1982-08       Impact factor: 5.422

6.  [Semi-synthesis and proposed structure of platelet-activating factor (P.A.F.): PAF-acether an alkyl ether analog of lysophosphatidylcholine].

Authors:  J Benveniste; M Tencé; P Varenne; J Bidault; C Boullet; J Polonsky
Journal:  C R Seances Acad Sci D       Date:  1979-11-26

7.  Platelet-activating factor. Evidence for 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators).

Authors:  C A Demopoulos; R N Pinckard; D J Hanahan
Journal:  J Biol Chem       Date:  1979-10-10       Impact factor: 5.157

8.  Potent ulcerogenic actions of platelet-activating factor on the stomach.

Authors:  A C Rosam; J L Wallace; B J Whittle
Journal:  Nature       Date:  1986 Jan 2-8       Impact factor: 49.962

9.  Biosynthesis of Paf-acether (platelet-activating factor). VII. Precursors of Paf-acether and acetyl-transferase activity in human leukocytes.

Authors:  E Jouvin-Marche; E Ninio; G Beaurain; M Tence; P Niaudet; J Benveniste
Journal:  J Immunol       Date:  1984-08       Impact factor: 5.422

10.  Release, purification, and characterization of platelet-activating factor (PAF).

Authors:  V Tencé; J Polonsky; J P Le Couedic; M J Benveniste
Journal:  Biochimie       Date:  1980       Impact factor: 4.079

View more
  15 in total

1.  More on pathogenesis and treatment of septic shock.

Authors:  D Fumarola; S Pece
Journal:  Eur J Epidemiol       Date:  1992-09       Impact factor: 8.082

Review 2.  Helicobacter pylori and peptic ulcers: the present position.

Authors:  S Moss; J Calam
Journal:  Gut       Date:  1992-03       Impact factor: 23.059

3.  Inflammatory signaling in NEC: Role of NF-κB, cytokines and other inflammatory mediators.

Authors:  Catherine J Hunter; Isabelle G De Plaen
Journal:  Pathophysiology       Date:  2013-12-31

4.  Increased gastric production of platelet-activating factor, leukotriene-B4, and tumor necrosis factor-alpha in children with Helicobacter pylori infection.

Authors:  A Hüseyinov; N Kütükçüler; S Aydogdu; S Caglayan; I Coker; D Göksen; R V Yagci
Journal:  Dig Dis Sci       Date:  1999-04       Impact factor: 3.199

5.  Isolation and structural elucidation of biologically active phospholipids from Scytonema julianum (cyanobacteria).

Authors:  Smaragdi Antonopoulou; Alexandra Oikonomou; Haralabos C Karantonis; Elizabeth Fragopoulou; Adriani Pantazidou
Journal:  Biochem J       Date:  2002-10-01       Impact factor: 3.857

6.  Helicobacter pylori and non-steroidal anti-inflammatory drugs: uncomfortable partners in peptic ulcer disease.

Authors:  A S Taha; R I Russell
Journal:  Gut       Date:  1993-05       Impact factor: 23.059

7.  Helicobacter pylori stimulates antral mucosal reactive oxygen metabolite production in vivo.

Authors:  G R Davies; N J Simmonds; T R Stevens; M T Sheaff; N Banatvala; I F Laurenson; D R Blake; D S Rampton
Journal:  Gut       Date:  1994-02       Impact factor: 23.059

8.  Gastric secretion of platelet activating factor and precursors in healthy humans: effect of pentagastrin.

Authors:  I Sobhani; Y Denizot; S Hochlaf; D Rigaud; J Vatier; J Benveniste; M J Lewin; M Mignon
Journal:  Gut       Date:  1993-08       Impact factor: 23.059

9.  Significance and regulation of gastric secretion of platelet-activating factor (PAF-acether) in man.

Authors:  I Sobhani; Y Denizot; C Vissuzaine; J Vatier; J Benveniste; M J Lewin; M Mignon
Journal:  Dig Dis Sci       Date:  1992-10       Impact factor: 3.199

10.  PAF-acether and acetylhydrolase in stool of patients with Crohn's disease.

Authors:  Y Denizot; S Chaussade; N Nathan; J F Colombel; M J Bossant; N Cherouki; J Benveniste; D Couturier
Journal:  Dig Dis Sci       Date:  1992-03       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.